Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Levodopa in the treatment of Parkinsonism.

× No keyword cloud information.

11 in total

1. A vesicular sequestration to oxidative deamination shift in myocardial sympathetic nerves in Parkinson's disease.

Authors: David S Goldstein; Patricia Sullivan; Courtney Holmes; Gary W Miller; Yehonatan Sharabi; Irwin J Kopin
Journal: J Neurochem Date: 2014-06-13 Impact factor: 5.372

2. The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.

Authors: J Gerlach; K Lühdorf
Journal: Psychopharmacologia Date: 1975-10-14

3. Certain prediction on the effectiveness of L-DOPA on parkinsonism.

Authors: S Lavy; O Abramsky; A Carmon; I Yaar; S Feldman
Journal: Z Neurol Date: 1973-02-26

Review 4. [Modern treatment of parkinsonism].

Authors: W Birkmayer; E Neumayer
Journal: Z Neurol Date: 1972

5. Nucleus ruber and L-dopa psychosis: biochemical post-mortem findings.

Authors: W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal: J Neural Transm Date: 1974 Impact factor: 3.575

6. Relationship between tardive dyskinesia, L-Dopa-induced hyperkinesia and parkinsonism.

Authors: J Gerlach
Journal: Psychopharmacology (Berl) Date: 1977-03-16 Impact factor: 4.530

7. Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.

Authors: David S Goldstein; Courtney Holmes; Yehonatan Sharabi
Journal: Brain Date: 2012-03-26 Impact factor: 13.501

8. The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.

Authors: Dieter Scheller; Christoph Ullmer; Reinhard Berkels; Mirella Gwarek; Hermann Lübbert
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2008-08-14 Impact factor: 3.000

Review 9. Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.

Authors: David S Goldstein; Irwin J Kopin; Yehonatan Sharabi
Journal: Pharmacol Ther Date: 2014-06-16 Impact factor: 12.310

10. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.

Authors: Roberto Cilia; Albert Akpalu; Fred Stephen Sarfo; Momodou Cham; Marianna Amboni; Emanuele Cereda; Margherita Fabbri; Patrick Adjei; John Akassi; Alba Bonetti; Gianni Pezzoli
Journal: Brain Date: 2014-07-17 Impact factor: 13.501